Ironwood Pharmaceuticals Inc (IRWD)
3.44
+0.10
(+2.99%)
USD |
NASDAQ |
Nov 22, 16:00
3.42
-0.02
(-0.58%)
After-Hours: 20:00
Ironwood Pharmaceuticals Total Assets (Quarterly): 389.52M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 389.52M |
June 30, 2024 | 395.62M |
March 31, 2024 | 438.82M |
December 31, 2023 | 471.07M |
September 30, 2023 | 524.06M |
June 30, 2023 | 603.22M |
March 31, 2023 | 1.155B |
December 31, 2022 | 1.101B |
September 30, 2022 | 1.040B |
June 30, 2022 | 975.69M |
March 31, 2022 | 1.083B |
December 31, 2021 | 1.127B |
September 30, 2021 | 1.079B |
June 30, 2021 | 1.007B |
March 31, 2021 | 599.34M |
December 31, 2020 | 559.24M |
September 30, 2020 | 492.32M |
June 30, 2020 | 443.54M |
March 31, 2020 | 404.00M |
December 31, 2019 | 402.75M |
September 30, 2019 | 334.34M |
June 30, 2019 | 315.72M |
March 31, 2019 | 363.54M |
December 31, 2018 | 332.05M |
September 30, 2018 | 416.65M |
Date | Value |
---|---|
June 30, 2018 | 618.22M |
March 31, 2018 | 571.10M |
December 31, 2017 | 605.67M |
September 30, 2017 | 625.09M |
June 30, 2017 | 705.08M |
March 31, 2017 | 701.32M |
December 31, 2016 | 709.82M |
September 30, 2016 | 731.98M |
June 30, 2016 | 700.21M |
March 31, 2016 | 603.32M |
December 31, 2015 | 619.12M |
September 30, 2015 | 613.43M |
June 30, 2015 | 653.94M |
March 31, 2015 | 305.53M |
December 31, 2014 | 329.32M |
September 30, 2014 | 346.17M |
June 30, 2014 | 371.06M |
March 31, 2014 | 418.87M |
December 31, 2013 | 278.96M |
September 30, 2013 | 325.84M |
June 30, 2013 | 384.03M |
March 31, 2013 | 325.09M |
December 31, 2012 | 229.91M |
September 30, 2012 | 246.52M |
June 30, 2012 | 208.66M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
389.52M
Minimum
Sep 2024
1.155B
Maximum
Mar 2023
714.61M
Average
579.29M
Median
Total Assets (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 3.877M |
Palatin Technologies Inc | 3.415M |
iBio Inc | 24.52M |
Theriva Biologics Inc | 40.11M |
Oragenics Inc | 5.204M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 700.85M |
Shareholders Equity (Quarterly) | -311.33M |
Debt to Equity Ratio | -1.923 |
Current Ratio | 3.617 |
Net Debt Paydown Yield | 6.01% |